李嘉誠向四間本地院校捐款1.7億元 支持多個科技項目
長和系資深顧問李嘉誠透過基金會向香港大學李嘉誠醫學院、香港中文大學醫學院、香港科技大學、香港教育大學捐資共1.7億元,以支持多個科技項目。
當中,1億元支持香港大學李嘉誠醫學院成立「低溫電子顯微設施研究中心」,引進諾貝爾得獎技術「Cryo-EM」;3,500萬元助建中文大學醫學院世界高水平的轉化組學平台,增設最先進的分析質譜儀系統;3,000萬元支持香港科技大學發展合成生物學科研,落實相關先進項目;500萬元資助香港教育大學與本地設計師合作,提升教材質素。
基金會指,是次是李嘉誠首次同時向四間本地大學捐款,已悉數把資助撥給四間院校。李嘉誠強調,香港醫護、科研、教育人才均甚具潛質,加上「憑仁善斷」的素養,定可繼續以專業服務香港。他又表示,生物醫學科技已成為解決各種生命難題的神幻鑰匙,AI「無碼」應用將是全方位能力提升的關鍵,面廣寸深的大類課程已不足支撐長遠競爭力,發展生物經濟產業、推動AI能力在香港普及,刻不容緩。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.